2 Firms Will Lead Investor Suit Over GW Pharma's $7.2B Deal

A California federal judge has appointed Monteverde & Associates and Kahn Swick & Foti as co-lead counsel of a proposed securities class action against GW Pharmaceuticals over claims that it misled...

Already a subscriber? Click here to view full article